Rhophylac is a Intramuscular; Intravenous Solution in the Plasma Derivative category. It is labeled and distributed by Csl Behring Ag. The primary component is Human Rho(d) Immune Globulin.
| Product ID | 44206-300_03b4c36d-5ef7-4ce4-ad3d-d375a1347905 |
| NDC | 44206-300 |
| Product Type | Plasma Derivative |
| Proprietary Name | Rhophylac |
| Generic Name | Human Rho(d) Immune Globulin |
| Dosage Form | Solution |
| Route of Administration | INTRAMUSCULAR; INTRAVENOUS |
| Marketing Start Date | 2009-01-06 |
| Marketing Category | BLA / BLA |
| Application Number | BLA125070 |
| Labeler Name | CSL Behring AG |
| Substance Name | HUMAN RHO(D) IMMUNE GLOBULIN |
| Active Ingredient Strength | 1500 [iU]/2mL |
| Pharm Classes | Human Immunoglobulin G [EPC],Passively Acquired Immunity [PE],Endogenous Antigen Neutralization [MoA],Immunoglobulins [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |
| Marketing Start Date | 2009-01-06 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | BLA |
| Application Number | BLA125070 |
| Product Type | PLASMA DERIVATIVE |
| Billing Unit | ML |
| Marketing Start Date | 2009-01-06 |
| Marketing Category | BLA |
| Application Number | BLA125070 |
| Product Type | PLASMA DERIVATIVE |
| Billing Unit | ML |
| Marketing Start Date | 2012-09-11 |
| Marketing Category | BLA |
| Application Number | BLA125070 |
| Product Type | PLASMA DERIVATIVE |
| Billing Unit | ML |
| Marketing Start Date | 2009-01-06 |
| Ingredient | Strength |
|---|---|
| HUMAN RHO(D) IMMUNE GLOBULIN | 1500 [iU]/2mL |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 44206-300 | Rhophylac | HUMAN RHO(D) IMMUNE GLOBULIN |
| 0562-7806 | MICRhoGAM Ultra-Filtered PLUS | HUMAN RHO(D) IMMUNE GLOBULIN |
| 0562-7805 | RhoGAM Ultra-Filtered PLUS | HUMAN RHO(D) IMMUNE GLOBULIN |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() RHOPHYLAC 75099325 2131797 Live/Registered |
CSL BEHRING AG 1996-05-06 |